DENINTUZUMAB
UNII 0LPG0J327L

Substance Identification & Data

This profile provides standardized clinical and technical data for Denintuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0LPG0J327L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1630074-14-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0LPG0J327L

CAS Registry Number

1630074-14-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DENINTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166425

National Cancer Institute reference terminology for clinical and research data.

USAN ID

CD-83

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Denintuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DENINTUZUMAB

Common Names & Synonyms

DENINTUZUMAB [USAN]

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD19 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HBU12 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HBU12 .KAPPA.-CHAIN, DIMER

Technical Codes

HBU12

HBU-12

External Clinical & Regulatory Resources

Previous UNII0LNL93U7V1

Next UNII0LQ049BKK3